"We Envision Growth Strategies Most Suited
to Your Business"
Education and awareness on sexual health and well-being have risen significantly with the ever-increasing global population over the past decade. Condom, a product which some people are ashamed to ask for out loud at a pharmacist, has witnessed an uptick in demand. From advertisements to avoid the contraction of sexually transmitted diseases (STDs), HIV, or unwanted pregnancies to online series such as “Sex Education” on Netflix, the increasing awareness about contraceptives and sexual health amongst both genders is playing a vital role in the global market growth. As per a report by Fortune Business Insights™, the market for condom was valued at USD 5.31 billion in 2020 and is expected to reach USD 10.97 billion by 2028, exhibiting a stellar CAGR of 9.4% during the 2021-2028 period.
The global coronavirus pandemic has potentially boosted the demand for the product. The distribution of 160,000 such products during the Tokyo Olympics 2020 certainly caught a lot of attention. Stay-at-home orders peaked during the pandemic; however, supply chain disruptions due to government-mandated lockdowns and curfews have affected the product demand. For instance, Durex reported loosened revenues in Q3 2020. Nonetheless, it is an essential commodity, and its demand is expected to grow prominently in the forthcoming years.
A famous British multinational consumer goods company offers several condom brands under nutritional, hygiene, and health products business. Durex, one of the company’s brands, is a pioneer in the global market. It has a strong foothold in the Europe market. It has production sites located in India, Thailand, the U.S., China, and the U.K.
In May 2020, Reckitt Benckiser Group Plc. entered into a strategic partnership with a Nigeria-based non-governmental organization, PPFN, a foremost provider of reproductive and sexual healthcare services. The partnership aimed to boost access to contraceptive products for consumers and business expansion in the country.
The company offers a broad range of ingenious condoms, lubricants, and other products. It has production sites located in Thailand, the U.S., India, China, Argentina, and Belgium. Its prominent condom brands include Manix, Jissbon, LifeStyles, and others. In July 2018, it launched Zero, a thin condom that comprised latex-based products and natural rubber.
A prominent Indian pharmaceutical company offering healthcare brands, including Prega News, Manforce, Gas-O-Fast, Unwanted 72, and others, has a presence across 34 countries and generates revenues of about USD 1 billion. The company has administered over 350 research and development scientists globally.
Manforce, a popular brand of Mankind Pharma, initiated the #YouAreNotAlone campaign in February 2020 to spread sexual awareness amongst people. The campaign also helped to boost the brand image of the company.
A leading manufacturer of specialty, personal care, and household products that holds approximately 400 contract manufacturers and suppliers globally. It offers ‘Trojan’ condom brand that boasts a strong presence across Europe, Canada, and Mexico. The company launched the ‘Ultra Fit’ condom line in June 2021 to fulfill the strong demand from males in the U.S. for such products.
A popular Indian manufacturing company with a robust production base in Maharashtra, India, is an exporter of the product to nearly 66 countries globally. The company encompasses a production capacity of 480 million male condoms and 52 million female condoms. In 2020, the company created a turnover of USD 22.52 million. As an industry development, the company obtained an order of male condoms worth USD 3.13 million in June 2020 from the Tanzanian government. This greatly aided the company expansion across the country.
The largest manufacturer in Malaysia can produce above 5,000 million condoms per year and generated USD 93.42 million worth of revenue in 2020. The company exports sexual wellbeing commodities to over 130 countries worldwide. In November 2020, the company acquired 30% equity in the Global Protection, U.S. to produce and supply its products in the U.S. market.
An oncology biopharmaceutical company based in the U.S. focused on developing avant-garde cancer treatment medicines. The company boasts its female condom brand called ‘F2C’, which utilizes nitrile-polymer-based formulations in its products and is present in above 140 countries globally. In 2019, the brand “F2C” reported doubled sales worth USD 30.9 million.
A pioneering rubber latex condom manufacturer/brand possesses seven sexual healthcare commodities’ production sites and a robust network of above 5,200 drug stores in India. The company also encompasses an exhaustive assortment of napkins and such products. It launched the “I’m Your Best Friend, I’ll Safeguard You” campaign in July 2021 to spread sexual health-related awareness amongst Indian consumers.
The company advertises and supplies top-quality reproductive and healthcare products, including contraceptive sponges, latex condoms, and other healthcare-related products across Canada and the U.S. It also showcases manufacturing partnerships in San Francisco, Los Angeles, Thailand, India, and China. It emphasizes business expansion by augmenting the production capacities and customer base.
A leading producer of such products in Japan possesses three production sites across Fukushima, Ibaraki, and Shizuoka. It has established subsidiaries in Thailand, Hong Kong, the U.S., Vietnam, and China for international business expansion. It emphasizes broadening awareness related to sexual health-related products and bolsters its sales from the Japanese market.
In conclusion, the demand for the product is expected to increase manifold in the coming years due to increasing sexual awareness amongst the global populace. Strategic campaigns and advertisements by companies are expected to surge the demand for the product. Moreover, the expansion of the companies to international markets is likely to provide lucrative growth opportunities in the coming years.